35 related articles for article (PubMed ID: 17029342)
21. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.
Pluta RM
Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036
[TBL] [Abstract][Full Text] [Related]
22. A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review.
Ehlert A; Manthei G; Hesselmann V; Mathias K; Bein B; Pluta R
World Neurosurg; 2016 Jul; 91():673.e11-8. PubMed ID: 27109628
[TBL] [Abstract][Full Text] [Related]
23. Role of nitric oxide and mechanisms involved in cerebral injury after subarachnoid hemorrhage: is nitric oxide a possible answer to cerebral vasospasm?
Crobeddu E; Pilloni G; Tardivo V; Fontanella MM; Panciani PP; Spena G; Fornaro R; Altieri R; Agnoletti A; Ajello M; Zenga F; Ducati A; Garbossa D
J Neurosurg Sci; 2016 Sep; 60(3):385-91. PubMed ID: 25600552
[TBL] [Abstract][Full Text] [Related]
24. The role of nitric oxide donors in treating cerebral vasospasm after subarachnoid hemorrhage.
Fathi AR; Bakhtian KD; Pluta RM
Acta Neurochir Suppl; 2011; 110(Pt 1):93-7. PubMed ID: 21116922
[TBL] [Abstract][Full Text] [Related]
25. Update on evidence for a genetic predisposition to cerebral vasospasm.
Khurana VG; Fox DJ; Meissner I; Meyer FB; Spetzler RF
Neurosurg Focus; 2006 Sep; 21(3):E3. PubMed ID: 17029342
[TBL] [Abstract][Full Text] [Related]
26. Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Rosalind Lai PM; Du R
World Neurosurg; 2015 Oct; 84(4):933-41.e2. PubMed ID: 26074429
[TBL] [Abstract][Full Text] [Related]
27. Relationship between endothelial nitric oxide synthase (eNOS) and natural history of intracranial aneurysms: meta-analysis.
Paschoal EHA; Yamaki VN; Teixeira RKC; Paschoal Junior FM; Jong-A-Liem GS; Teixeira MJ; Yamada ES; Ribeiro-Dos-Santos Â; Bor-Seng-Shu E
Neurosurg Rev; 2018 Jan; 41(1):87-94. PubMed ID: 27339197
[TBL] [Abstract][Full Text] [Related]
28. Genetic modification of cerebral arterial wall: implications for prevention and treatment of cerebral vasospasm.
Vijay A; Santhanam R; Katusic ZS
Neurol Res; 2006 Oct; 28(7):759-68. PubMed ID: 17164039
[TBL] [Abstract][Full Text] [Related]
29. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
Pluta RM
Pharmacol Ther; 2005 Jan; 105(1):23-56. PubMed ID: 15626454
[TBL] [Abstract][Full Text] [Related]
30. The role of apolipoprotein e in the pathological events following subarachnoid hemorrhage: a review.
Guo ZD; Sun XC; Zhang JH
Acta Neurochir Suppl; 2011; 110(Pt 2):5-7. PubMed ID: 21125436
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
